Evidence map›Paper›PMID 32604721›Full record

ArticleNutrients2020

Effects of 3-Month Astaxanthin Supplementation on Cardiac Function in Heart Failure Patients with Left Ventricular Systolic Dysfunction-A Pilot Study.

Takao Kato, Takatoshi Kasai, Akihiro Sato, Sayaki Ishiwata, Shoichiro Yatsu, Hiroki Matsumoto, Jun Shitara, Azusa Murata, Megumi Shimizu, Shoko Suda and 3 more

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 39 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Takao KatoDepartment of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.
Takatoshi KasaiDepartment of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.ORCID 0000-0001-5747-7668
Akihiro SatoDepartment of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.
Sayaki IshiwataDepartment of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.
Shoichiro YatsuDepartment of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.
Hiroki MatsumotoDepartment of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.
Jun ShitaraDepartment of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.
Azusa MurataDepartment of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.
Megumi ShimizuDepartment of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.
Shoko SudaDepartment of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.
Masaru HikiDepartment of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.
Ryo NaitoDepartment of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.
Hiroyuki DaidaDepartment of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.
Juntendo University · JP

Funding

AstaReal Co., Ltd 11Grant-in-Aid for Scientific Research 26507010JSPS KAKENHI JP17K09527MEXT∗-Supported Program for the Strategic Research Foundation at Private Universities, 2014-2018 (∗Ministry of Education, Culture, Sports, Science and Technology) 11The Intractable Respiratory Diseases and Pulmonary Hypertension Research Group from the Ministry of Health, Labor and Welfare H29-027
6 · The paper itself

Abstract

Astaxanthin has strong antioxidant properties. We conducted a prospective pilot study on heart failure (HF) patients with left ventricular (LV) systolic dysfunction to investigate improvements in cardiac function and exercise tolerance in relation to suppression of oxidative stress by 3-month astaxanthin supplementation. Oxidative stress markers-serum Diacron reactive oxygen metabolite (dROM), biological antioxidant potential (BAP), and urinary 8-hydroxy-2'-deoxyguanosine (8-OHdG) concentrations, LV ejection fraction (LVEF), and 6-min walk distance (6MWD) were assessed before and after 3-month astaxanthin supplementation. Finally, the data of 16 HF patients were analyzed. Following 3-month astaxanthin supplementation, dROM level decreased from 385.6 ± 82.6 U.CARR to 346.5 ± 56.9 U.CARR (

Indexed as

AgedAntioxidantsDietary SupplementsExercise ToleranceFemaleHeart FailureHumansMaleMiddle AgedMyocardial ContractionOxidative StressPilot ProjectsProspective StudiesStroke VolumeVentricular Dysfunction, LeftVentricular Function, LeftAntioxidantsastaxanthineXanthophylls6-min walk testantioxidantleft ventricular ejection fractionoxidative stress

Identifiers

PMID32604721
PMCPMC7353230
OpenAlexW3037567807

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.